Ascendis Pharma AS (A71) — Long-term Investment Intensity
Ascendis Pharma AS (A71) has a Long-term Investment Intensity of 1.2% as of March 2026. Long-term investments of €23.56 Million represent 1.2% of total assets of €2.00 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Ascendis Pharma AS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ascendis Pharma AS Long-term Investment Intensity (2018–2025)
This chart shows how Ascendis Pharma AS's Long-term Investment Intensity has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the intensity stands at 1.2%, reflecting long-term investments of €23.56 Million against total assets of €2.00 Billion EUR. For the complete balance sheet picture, see A71 asset base.
Annual Long-term Investment Intensity for Ascendis Pharma AS (2018–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ascendis Pharma AS from 2018 to 2025, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Ascendis Pharma AS for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 2.5% | €32.53 Million | €1.30 Billion | ▲ +1.3 pp |
| 2024 | 1.2% | €13.57 Million | €1.18 Billion | ▲ +0.5 pp |
| 2023 | 0.7% | €5.69 Million | €825.59 Million | ▼ -2.1 pp |
| 2022 | 2.8% | €30.42 Million | €1.09 Billion | ▼ -10.7 pp |
| 2021 | 13.4% | €145.91 Million | €1.08 Billion | ▲ +0.7 pp |
| 2020 | 12.7% | €124.46 Million | €979.79 Million | ▲ +10.4 pp |
| 2019 | 2.3% | €15.54 Million | €676.73 Million | ▼ -3.1 pp |
| 2018 | 5.4% | €17.08 Million | €318.97 Million | — |